Given the serious side-effects of hyperprolactinemia and the possibilities for changing management by lowering dosage or switching to a different antipsychotic, we propose routinely monitoring prolactin levels in patients who are prescribed antipsychotics. The gene discussed is PRL; the disease is hyperprolactinemia.